Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Doxycycline Hyclate
Divasa - Farmavic S.A
QJ01AA02
Doxycycline Hyclate
Solution for use in drinking water
POM-V - Prescription Only Medicine – Veterinarian
Chickens, Pigs
Antimicrobial
Authorized
2011-07-12
Revised: May 2016 AN: 01226/2015 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT DFV DOXIVET 200 mg/ml, solution for use in drinking water for pigs and chickens. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Composition for 1 ml: ACTIVE SUBSTANCE: Doxycycline hyclate 230 mg Equivalent to 200 mg doxycycline base EXCIPIENTS: For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for use in drinking water Clear yellow-brown solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs and chickens (broiler, pullet, breeder). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Pigs: For the treatment of the clinical signs associated with porcine respiratory disease caused by _Actinobacillus pleuropneumoniae, Pasteurella multocida_, and _Mycoplasma _ _hyopneumoniae _susceptible to doxycycline. Chickens: Where clinical disease is present in the flock, to reduce mortality, morbidity, and clinical signs and to reduce lesions due to Pasteurellosis caused by _Pasteurella multocida _ or to reduce morbidity and lesions in respiratory infections caused by _Ornithobacterium _ _rhinotracheale (ORT)_. 4.3 CONTRAINDICATIONS Do not use in case of hypersensitivity to the active substance or to any of the excipients. Do not use in animals with an impaired liver function. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Revised: May 2016 AN: 01226/2015 Page 2 of 6 Due to likely variability (time, geographical) in susceptibility of bacteria for doxycycline, especially susceptibility of _A. pleuropneumoniae _and _O. rhinotracheale _may differ from country to country and even farm to farm, bacteriological sampling and susceptibility testing are recommended. Use of the product should be based on culture and sensitivity of micro-organisms from diseased cases on farm. If this is not possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the Read the complete document